Peptidomimetic small-molecule compounds promoting cardiogenesis of stem cells

Archives of Pharmacal Research

Volumn 35, Issue 11, 2012, Pages 1979-1988

  Oh, Se Woong ^a   Lee, Jung Bok ^b   Kim, Bora ^c   Jeon, Sejin ^c   Kim, Min Kyoung ^a   Nam, Ki Hoan ^d   Ha, Jong Ryul ^a   Bhatia, Mickie ^b   Oh, Goo Taeg ^c   Kim, Dae Yong ^e  

^a JW Pharmaceutical Corporation   (South Korea)

^b MCMASTER UNIVERSITY   (Canada)

^c Ewha Womans University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Cardiogenesis; Embryonic stem cells; Ischemic heart disease; Peptidomimetic compounds

Indexed keywords

ALPHA ACTININ; CARDIOGENOL C; CW 209E; ENHANCED GREEN FLUORESCENT PROTEIN; MYOSIN HEAVY CHAIN ALPHA; PEPTIDOMIMETIC AGENT; TRANSCRIPTION FACTOR SOX6; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOTOXICITY; EMBRYOID BODY; EMBRYONIC STEM CELL; EX VIVO STUDY; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOLECULAR LIBRARY; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84874428014     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-1115-6     Document Type: Article

References (41)

1. rd, Chi, X.; Garcia-Gras, E.; Shirai, M.; Feng, X. H.; and Schwartz, R. J.; The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer. J. Biol. Chem.; 279, 10659-10669 (2004).
2. Bu, L.; Jiang, X.; Martin-Puig, S.; Caron, L.; Zhu, S.; Shao, Y.; Roberts, D. J.; Huang, P. L.; Domian, J. J.; and Chien, K. R.; Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature, 460, 113-117 (2009).
3. Chadwick, K.; Wang, L.; Li, L.; Menendez, P.; Murdoch, B.; Rouleau, A.; and Bhatia, M.; Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood, 102, 906-915 (2003).
4. Christoforou, N.; Miller, R. A.; Hill, C. M.; Jie, C. C.; McCallion, A. S.; and Gearhart, J. D.; Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J. Clin. Invest.; 118, 894-903 (2008).
5. Ding, S. and Schultz, P. G.; A role for chemistry in stem cell biology. Nat. Biotechnol.; 22, 833-840 (2004).
6. Duque, G. and Rivas, D. J.; Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells. Bone Miner. Res.; 22, 1603-1611 (2007).
7. Durocher, D.; Chen, C. Y.; Ardati, A.; Schwartz, R. J.; and Nemer, M.; The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol. Cell. Biol.; 16, 4648-4655 (1996).
8. Epstein, J.; Cardiac development and implications for heart disease. N. Engl. J. Med.; 363, 1638-1647 (2010).
9. Fehling, H. J.; Lacaud, G.; Kubo, A.; Kennedy, M.; Robertson, S.; Keller, G.; and Kouskoff, V.; Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development, 130, 4217-4227 (2003).
10. Hamada-Kanazawa, M.; Ishikawa, K.; Nomoto, K.; Uozumi, T.; Kawai, Y.; Narahara, M.; and Miyake, M.; Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid. FEBS Lett.; 560, 192-198 (2004).
11. Henning, R. J.; Stem cells in cardiac repair. Future Cardiol.; 7, 99-117 (2011).
12. Hong, S. H.; Lee, J. H.; Lee, J. B.; Ji, J.; and Bhatia, M.; ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis. J. Cell Sci.; 124, 1445-1452 (2011).
13. Hosseinkhani, M.; Hasegawa, K.; Ono, K.; Kawamura, T.; Takaya, T.; Morimoto, T.; Wada, H.; Shimatsu, A.; Prat, S. G.; Suemori, H.; Nakatsuji, N.; and Kita, T.; Trichostatin A induces myocardial differentiation of monkey ES cells. Biochem. Biophys. Res. Commun.; 356, 386-391 (2007).
14. Kattman, S, J.; Huber, T. L.; and Keller, G. M.; Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell, 11, 723-732 (2006).
15. Keller, G. M.; In vitro differentiation of embryonic stem cells. Curr. Opin. Cell Biol.; 7, 862-869 (1995).
16. McMillan, M. and Kahn, M.; Investigating Wnt signaling: a chemogenomic safari. Drug Discov. Today, 10, 1467-1474 (2005).
17. Okita, K.; Ichisaka, T.; and Yamanaka, S.; Generation of germline-competent induced pluripotent stem cells. Nature, 448, 313-317 (2007).
18. Paige, S. L.; Osugi, T.; Afanasiev, O. K.; Pabon, L.; Reinecke, H.; and Murry, C. E.; Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One, 5, e11134 (2010).
19. Passier, R.; van Aaake, L. W.; and Mummery, C. L.; Stem-cellbased therapy and lessons from the heart. Nature, 453, 322-329 (2008).
20. Pesce, M. and Schöler, H. R.; Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells, 19, 271-278 (2001).
21. Pouton, C. W. and Haynes, J. M.; Embryonic stem cells as a source of models for drug discovery. Nat. Rev. Drug Discov.; 6, 605-616 (2007).
22. Rajala, K.; Pekkanen-Mattila, M.; and Aalto-Setälä, K.; Car diac differentiation of pluripotent stem cells. Stem Cells Int.; 2011, 383709 (2011).
23. Roggia, C.; Ukena, C.; Böhm, M.; and Kilter, H.; Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase. Exp. Cell Res.; 313, 921-930 (2007).
24. Rose, R. A.; Jiang, H.; Wang, X.; Helke, S.; Tsoporis, J. N.; Gong, N.; Keating, S. C.; Parker, T. G.; Backx, P. H.; and Keating, A.; Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells, 26, 2884-2892 (2008).
25. Sachinidis, A.; Schwengberg, S.; Hippler-Altenburg, R.; Mariappan, D.; Kamisetti, N.; Seelig, B.; Berkessel, A.; and Hescheler, J.; Identification of small signalling molecules promoting cardiac-specific differentiation of mouse embryonic stem cells. Cell. Physiol. Biochem.; 18, 303-314 (2006).
26. Sadek, H.; Hannack, B.; Choe, E.; Wang, J.; Latif, S.; Garry, M. G.; Garry, D. J.; Longgood, J.; Frantz, D. E.; Olson, E. N.; Hsieh, J.; and Schneider, J. W.; Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc. Natl. Acad. Sci. U. S. A.; 105, 6063-6068 (2008).
27. Samuel, L. J. and Latinkić, B. V.; Early activation of FGF and nodal pathways mediates cardiac specification independently of Wnt/beta-catenin signaling. PLoS One, 4, e7650 (2009).
28. Schugar, R. C.; Robbins, P. D.; and Deasy, B. M.; Small molecules in stem cell self-renewal and differentiation. Gene Ther.; 15, 126-135 (2008).
29. Segers, V. F. and Lee, R. T.; Stem-cell therapy for cardiac disease. Nature, 451, 937-942 (2008).
30. Takahashi, T.; Lord, B.; Shulze, P. C.; Fryer, R. M.; Sarang, S. S.; Gullans, S. R.; and Lee, R. T.; Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation, 107, 1912-1916 (2003).
31. Takei, S.; Ichikawa, H.; Johkura, K.; Mogi, A.; No, H.; Yoshie, S.; Tomotsune, D.; and Sasaki, K.; Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development. Am. J. Physiol. Heart Circ. Physiol.; 296, H1793-H1803 (2009).
32. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; and Jones, J. M.; Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147 (1998).
33. Wang, L.; Li, L.; Shojaei, F.; Levac, K.; Cerdan, C.; Menendez, P.; Martin, T.; Rouleau, A.; and Bhatia, M.; Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity, 21, 31-41 (2004).
34. Wei, Z. L.; Petukhov, P. A.; Bizik, F.; Teixeira, J. C.; Mercola, M.; Volpe, E. A.; Glazer, R. I.; Willson, T. M.; and Kozikowski, A. P.; Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation. J. Am. Chem. Soc.; 126, 16714-16715 (2004).
35. Willems, E.; Bushway, P. J.; and Mercola, M.; Natural and synthetic regulators of embryonic stem cell cardiogenesis. Pediatr. Cardiol.; 30, 635-642 (2009).
36. Willems, E.; Lanier, M.; Forte, E.; Lo, F.; Cashman, J.; and Mercola, M.; A chemical biology approach to myocardial regeneration. J. Cardiovasc. Transl. Res.; 4, 340-350 (2011).
37. Wu, X.; Ding, S.; Gray, N. S.; and Schultz, P. G.; Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc.; 126, 1590-1591 (2004).
38. Xu, C.; Inokuma, M. S.; Denham, J.; Golds, K.; Kundu, P.; Gold, J. D.; and Carpenter, M. K.; Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol.; 19, 971-974 (2001).
39. Xu, C.; Police, S.; Rao, N.; and Carpenter, M. K.; Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res.; 91, 501-508 (2002).
40. Yang, L.; Soonpaa, M. H.; Adler, E. D.; Roepke, T. K.; Kattman, S. J.; Kennedy, M.; Henckaerts, E.; Bonham, K.; Abbott, G. W.; Linden, R. M.; Field, L. J.; and Keller, G. M.; Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature, 453, 524-528 (2008).
41. Yoon, B. S.; Yoo, S. J.; Lee, J. E.; You, S.; Lee, H. T.; and Yoon, H. S.; Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation, 74, 149-159 (2006).